CLINICAL_TRIALS
trial_result
· 2015-05-12
Clinical Trial Update: Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood [Phase 1]
Summary
Phase 1 study comparing subcutaneous versus intravenous administration of epratuzumab in systemic lupus erythematosus has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Biopharma S.P.R.L. | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED